share_log

Connect Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Panacea Innovation Limited(16.2%),Panacea Venture Healthcare Fund II, L.P.(16.2%), etc.

康乃德生物 | SC 13D:超过5%持股股东披露文件-Panacea Innovation Limited(16.2%),Panacea Venture Healthcare Fund II, L.P.(16.2%)等

SEC announcement ·  02/13 16:38
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息